Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Other Non Operating Income (2021 - 2026)

Updated

Filana Therapeutics' Other Non Operating Income came in at $207,000 for Q2 2026, up 32.7% from $156,000 a year earlier but down 18.2% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Other Non Operating Income (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Filana Therapeutics reported Other Non Operating Income of $822,000, up 24.4% year-over-year; for FY2025, it was $736,000.

  • Other Non Operating Income carries a four-year compound annual growth rate of -5.2% (FY2021 to FY2025).
  • Going back by year, Other Non Operating Income was -$108.18 million in FY2024, $2.28 million in FY2023 (-7.2%), $2.46 million in FY2022 (+169.9%) and $911,000 in FY2021.
  • The five-year range for quarterly Other Non Operating Income is -$65.14 million (Q2 2024) to $735,000 (Q4 2021).
  • Year-over-year, Other Non Operating Income increased in two of the last four quarters, with an average decline of 5.4%.
  • The fastest year-over-year change in Other Non Operating Income over five years came in Q3 2022 (growth of 252.3%), and the weakest in Q3 2024 (a decline of 50.6%).
  • Business Quant data shows FLNA's Other Non Operating Income at $253,000 (Q1 2026), $132,000 (Q4 2025) and $230,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Filana Therapeutics 31.40 Mn -339.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 207,000.00
Mar 31, 2026 253,000.00
Dec 31, 2025 132,000.00
Sep 30, 2025 230,000.00
Jun 30, 2025 156,000.00
Mar 31, 2025 217,000.00
Sep 30, 2024 288,000.00
Jun 30, 2024 -65.14 Mn
Mar 31, 2024 -43.04 Mn
Dec 31, 2023 584,000.00
Sep 30, 2023 583,000.00
Jun 30, 2023 559,000.00
Mar 31, 2023 557,000.00
Dec 31, 2022 679,000.00
Sep 30, 2022 620,000.00
Jun 30, 2022 275,000.00
Mar 31, 2022 263,000.00
Dec 31, 2021 735,000.00
Sep 30, 2021 176,000.00
API Access

Filana Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FLNA&period=max&api_key=YOUR_API_KEY